KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
Cheminant M, Lhermitte L, Bruneau J, Sicard H, Bonnafous C, Touzart A, Bourbon E, Ortonne N, Genestier L, Gaulard P, Palmic P, Suarez F, Frenzel L, Naveau L, Bazarbachi A, Dussiot M, Waast L, Avettand-Fenoel V, Brouzes C, Pique C, Lepelletier Y, Asnafi V, Marçais A, Hermine O.
Cheminant M, et al. Among authors: palmic p.
Blood. 2022 Sep 29;140(13):1522-1532. doi: 10.1182/blood.2022016765.
Blood. 2022.
PMID: 35687761
Free article.
Clinical Trial.